Microarray RNA gene expression profiling analysis has shown that Sox4 (Sry-related high mobility group (HMG) box 4) is one of the most upregulated genes in adenoid cystic carcinoma (ACC), relative to non-neoplastic tissue of origin. Here, we show that Sox4 protein is similarly upregulated in ACC by immunohistochemistry of 28 primary cancers and 20 normal tissues. To elucidate the functional significance of these findings, RNA interference (RNAi)-mediated RNA silencing was used to downregulate Sox4 expression in the ACC-derived cell line, ACC3. With confirmed knockdown of Sox4 protein, cell viability was reduced by 51%, with a corresponding increase of apoptosis to 85% as compared to 12% in controls. Apoptosis was confirmed by cell morphology, DNA fragmentation and flow cytometry. Cells could be rescued from the proapoptotic effects of Sox4 RNAi by co-transfection with a construct expressing functional Sox4. Microarray gene expression profiling of RNAi knockdown experiments shows that downregulation of Sox4-modulated expression of critical genes involved in apoptosis and cell cycle control. Overall, our findings suggest that Sox4 contributes to the malignant phenotype of ACC cells by promoting cell survival.
Introduction
Sry-related high mobility group (HMG) box 4 (Sox4)is a member of a large family of transcription factors that share homology in their DNA-binding domain, the socalled HMG-box (van de Wetering et al., 1993; Wegner, 1999) . High mobility group box proteins bind DNA directly, predominantly to the minor groove of the DNA helix at the consensus sequence A/TA/T CAA A/T G (van de Wetering and Clevers, 1992) . Sox4 is expressed in a number of tissues during embryonic development, including the heart, central nervous system, lungs and thymus (Wegner, 1999) . Sox4 is also expressed in mouse uterus and its expression is regulated by ovarian hormones, suggesting a developmental role of this gene in the female reproductive system (Hunt and Clarke, 1999) . Mice genetically deficient in Sox4 die during embryogenesis because of a failure in endocardial ridge development in the heart. Introduction of bone marrow cells from Sox4 null animals into an irradiated host results shows that B-lymphocyte development is impaired at pro-B cell stage (Schilham et al., 1996) . These findings suggest that Sox4 is involved in developmental processes occurring both in embryogenesis and in the mature animal.
There is mounting evidence suggesting the involvement of Sox4 in tumorigenesis. In particular, Sox4 is found to be one of the most frequently targeted genes in retroviral insertional mutagenesis studies, leading to neoplastic transformation in murine hematopoietic cells (Lund et al., 2002; Suzuki et al., 2002) . Transfection of normal murine bone marrow cells with a Sox4-expressing retrovirus induces myeloid leukemias (Du et al., 2005) . Sox4 is overexpressed in many types of human cancers relative to non-neoplastic tissue, and a meta-analysis of available gene expression profiling data identified Sox4 as a member of a consensus gene expression 'cancer signature' (Rhodes et al., 2004) . In colon carcinoma, aberrant expression of Sox4 has been implicated in the upregulation of the p56 lck , a member of the src tyrosine kinase family, whose expression appears to correlate with tumorigenic or metastatic potential in vivo (McCracken et al., 1997) . In addition, transcriptional profiles of intestinal tumors in Apc Min mice have shown that Sox4 is significantly upregulated in gastrointestinal adenomas indicating that Sox4 might play a role in Wnt pathway signaling (Reichling et al., 2005) . However, in general, the role of Sox4 in the development or maintenance of the malignant cell phenotype has not been well studied.
In a previous RNA microarray profiling analysis of adenoid cystic carcinoma (ACC) of salivary gland origin, we found that Sox4 was one of the most upregulated genes in relative to normal salivary glands (Frierson et al., 2002) . ACC is one of the most common subtypes of the salivary gland cancer (Vander Poorten et al., 1999) , but also arises in the nasopharynx, tracheobronchial tree, breast and vulva. ACC characteristically exhibits myoepithelial differentiation, and is a slow growing but highly malignant neoplasm with a high incidence of recurrence. The molecular alterations that underlie the tumor development and progression are poorly understood. To determine if the high level of Sox4 gene expression plays a role in the pathogenesis of ACC, we used RNA silencing (RNAi) technology to inhibit Sox4 expression in the ACC-derived cell line ACC3 (Cheng et al., 1995) and assayed parameters of cell growth and apoptosis. We also identified relevant target genes that are differentially expressed in the Sox4 knockdown ACC3 using oligonucleotide microarray technology.
Results
Differential immunoreactivity of Sox4 in adenoid cystic carcinoma and normal salivary gland samples To extend our previous results of microarray gene expression profiling that showed upregulation of Sox4 transcript in primary samples of ACC (Frierson et al., 2002) , we conducted immunohistochemistry of TMA containing 28 cases of primary ACC and 20 cases of non-neoplastic salivary gland tissue with Sox4 antibody. All cases of ACC showed nuclear and cytoplasmic staining with anti-Sox4 antibody (Figure 1) , with the majority of cases showing nuclear staining in greater than 50% of tumor cells. In non-neoplastic salivary gland epithelium, there was a wider range of Sox4 expression detected in the population of samples; however, the mean level of cells with nuclear staining was significantly lower in non-neoplastic epithelium compared to carcinoma cells (P ¼ 0.0009) (Figure 1g ). There was also qualitatively less cytoplasmic staining in benign glandular epithelium than in the carcinoma cells.
Sox4 RNA interference specifically reduces Sox4 expression in the ACC3 cell line To understand the significance of Sox4 upregulation in ACC, we first employed double-stranded RNA (dsRNA) nucleotides RNAi gene silencing to reduce Sox4 expression in the ACC3 cell line. Two small interfering RNA (siRNAs) (S1 and S2) were designed to target different regions of the Sox4 messenger RNA (mRNA). BLAST analysis shows no homology of the siRNA sequences to any other sequence in the Human Genome Database, including other member of the Sox gene family (Figure 2 ). Both S1 and S2 siRNAs significantly decreased Sox4 mRNA as shown by semiquantitative RT-PCR at 72 h after transfection (Figure 3a) . Quantitative RT-PCR showed a level of 0.2070.014 of Sox4 transcript (relative to b2M) in ACC3 cells when transfected with a scrambled RNA control. Sox4 mRNA was significantly reduced to 0.0370.004 and 0.0470.003 by treatment with the S1 and S2 siRNAs, respectively. Thus, there was a 67-fold decrease of Sox4 transcript in the S1 siRNA-treated cells and a 50-fold decrease in the S2 siRNA-treated cells, as compared to the control.
Sox4 RNA interference induces apoptosis in the ACC3 cell line Propidium iodide staining followed by flow cytometry analysis showed that knockdown of Sox4 by S1 and S2 siRNAs-induced apoptosis in ACC3 cells. As shown in Figure 3b , the percent of apoptotic cells in S1 and S2 siRNA-treated ACC3 cells was 37.3672.09 and 31.3171.69%, respectively. In contrast, only 13.7170.04% apoptotic cells were found in the scrambled siRNA control. As inducing RNAi with siRNAs or plasmid-based constructs can activate a nonspecific interferon viral defense mechanism that can lead to an arrest of protein synthesis and nonspecific mRNA degradation (Sledz et al., 2003) , we quantitated the amount of interferon-inducible genes in our system to ensure that the effect we observed were Sox4 specific and not due to the nonspecific differential induction of the interferon pathway. Semiquantitative RT-PCR of Sox4 knockdown induces apoptosis P Pramoonjago et al two interferon-induced genes, IRF1 and IFIT1 (Jackson et al., 2003; Sledz et al., 2003) , showed that the expression of both genes in cells with different treatments was indistinguishable (Figure 3c and d) .
We next tested whether vector-based shRNAs system, that supply continuous siRNA in the cells, would have a stronger effect on Sox4 gene silencing in ACC3. Indeed, clones carrying Sox4 shRNA (pENTR/S1), which had the same target sequence as the S1 siRNA oligonucleotide, significantly decreased the Sox4 mRNA level by semiquantitative and real-time PCR (Figure 4a and c) . The maximum reduction in transcript level was observed at 72 h after transfection. Immunoblot analysis showed that Sox4 protein levels were correspondingly reduced by 90% after 72 h (Figure 4b ). The levels of RNA and protein decrease were similar when simultaneously assayed (Figure 4a and b) . In contrast, Sox4 mRNA and protein levels were not significantly decreased in cells transfected with control plasmids carrying a 1 bp deletion in the Sox4 shRNA sequence (pENTR/S1-1) or a bacterial lacZ shRNA pENTR/LacZ, compared to mock-transfected cells (Figure 4 ). This result demonstrated that vector-based shRNA is more effective in Sox4 gene silencing in ACC3 cells than the oligonucleotide system, we therefore employed the vector-based system for our further studies.
As expected, cell viability decreased in pENTR/S1-transfected ACC3 cells from 77.171.6% in 24 h to Figure 2 Matching of sequences in the Sox gene family to Sry-related high mobility group box 4 (Sox4) RNA interference (RNAi) S1 and S2 sequences.
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P Pramoonjago et al 39.873.0% in 72 h (Figure 4d ). The majority of cells in these preparations rounded up, decreased in size and detached from the dish, morphologic changes consistent with apoptosis ( Figure 5c ). In striking contrast, cells transfected with control pENTR/S1-1 or the pENTR/ LacZ plasmids had growth and morphological characteristics indistinguishable from mock-transfected cells (Figure 5a and b), indicating lack of nonspecific toxic effects of vector-generated RNA duplexes and transfection treatment.
To further confirm the presence of apoptosis secondary to Sox4 knockdown, the level of DNA fragmentation was determined by TdT-mediated dUTP biotin nick end labeling (TUNEL) assay. As shown in Figure 6a , 83.7% of cells transfected with the Sox4 shRNA vectors were TUNEL positive as compared to 23.8% for the 1 bp shRNA deletion vector and 12.6% for mocktransfected cells. Corroborating this observation, propidium iodide staining followed by flow cytometry analysis showed that most cells subjected to Sox4 knockdown accumulated in the sub-G1 phase of the cell cycle (91.2%), consistent with apoptotic cells. In contrast, only 10.4, 12.1 and 5.6% of controls (pENTR/ LacZ, pENTR/S1-1 and mock transfection, respectively) were found in the sub-G1 phase (Figure 6b ). The accumulation of apoptotic cells in sub-G1 phase after transfections of pENTR/U6 clone was time dependent, increasing from B23% at 24 h to B89% at 72 h (Figure 6c ) while in control groups, the fraction of the apoptotic cells remained the same at the two time points. This result is consistent with the data obtained with synthetic siRNA oligonucleotides knockdown.
Apoptosis is a result of proteolytic cascade activity of enzymes involving cystein aspartyl proteases, or caspases that were triggered by the release of cytochrome c (cyt c) from mitochondrial membrane (Nguyen and Wells, 2003) . To confirm that Sox4 RNAi induces apoptosis in ACC cells via this caspase cascade, we treated the cells with a general caspase inhibitor, Z-VAD-FMK (Lu et al., 2004; McEleny et al., 2004) . As shown, Z-VAD-FMK reduced the apoptotic rate at 48 h from 40.5 to 15.0% for pENTR/S1 (Figure 6d ) and the effect of Z-VAD-FMK was dose dependent (data not shown). The same concentration of Z-VAD-FMK had no significant effect on the growth of the control cells (Figure 6d ). These results indicate that apoptosis caused by Sox4 knockdown in ACC3 is caspase dependent.
Expression of exogenous Sox4 reverses the proapoptotic effect of Sox4 small interfering RNA To further show that the observed apoptosis in the preceding experiments is indeed caused by specific downregulation the Sox4 protein and is not due to offtarget effects, we introduced exogenous Sox4 into the Sox4 knockdown cells. We constructed an expression vector containing a Sox4 gene containing a V5 tag. This recombinant Sox4 retained transcriptional activity, stimulating a luciferase reporter construct in a dosedependent manner (Figure 7a ). The exogenous Sox4 in the transfected ACC3 cells was detected by Western Sox4 knockdown induces apoptosis P Pramoonjago et al blotting against Sox4 and anti-V5 tag antibodies (data not shown).
We then generated an inducible Sox4 silencing system by transfecting ACC3 cells with a Tet repressorexpressing plasmid, followed by a plasmid carrying the S1 Sox4 siRNA sequence under tetracycline operator control. As shown in Figure 6b , cells containing these constructs exhibited a 40-50% decrease in viability with the addition of doxycycline, consistent with the effects of Sox4 siRNA knockdown. Whereas a slight decrease in viability was also noted in the control cells with the addition of doxycycline, the magnitude was far less than in the cells with the Sox4 siRNA construct, and represents an effect on the cells not related to the induction of dsRNA.
To determine whether the exogenous Sox4 could rescue the proapoptotic effect of Sox4 siRNA, ACC3 cells with induced Sox4 shRNA were transfected with various concentration of Sox4 expression plasmid. Exogenous Sox4 was able to rescue the viability of the ACC3 cells undergoing induction of Sox4 shRNA knockdown ( Figure 7b ). There was a significant diminishment of the shRNA effect even at the lowest concentration of the Sox4 expression vector used in our experiment, however, there is a dose response consistent with the titration of the constant shRNA levels by increasing amounts of exogenous Sox4 transcript. This result is further indication that the observed apoptosis in our experimental systems is indeed caused by downregulating Sox4 gene expression.
Microarray analysis of gene expression induced by Sox4
RNA interference To identify genes influenced by Sox4 expression, we used oligonucleotide microarrays to compare the expression level of 14 500 known genes in ACC3 cells that were transfected with Sox4 RNAi or a LacZ RNAi control (in triplicate). Two different analyses were performed to identify genes from this experiment that are potentially regulated by Sox4. The first analysis uses a stringent significance cutoff (Po0.01) and random resampling, resulting in the identification of probe sets that are most consistently different between the experimental and control groups, irregardless of fold change between the groups. This analysis yielded 25 genes, and this list is shown in Table 1 and Figure 8 . The second analysis ranks genes on the basis on the greatest degree of differential expression between the experimental and control group, with a probability significance of Figure 4 Vector-based RNAi gene silencing of Sry-related high mobility group box 4 (Sox4) gene expression. ACC3 cells were transfected with plasmids containing a Sox4 short hairpin RNA (shRNA) sequence (pENTR/S1), or a plasmid containing a 1 bp deletion of the SOX4 shRNA (pENTR/S1-1) or a plasmid containing an shRNA sequence to the bacterial LacZ gene (pENTR/LacZ) or were mock transfected. At 72 h, total RNA and protein were extracted. (a) Total RNA was analysed by duplex reverse transcription-polymerase chain reaction (RT-PCR) for Sox4 and b2-microglobulin (B2M). Only the shRNA with perfect complimentarity (S1) causes diminishment of the Sox4 transcript. (b) Protein was analysed by immunoblotting using anti-Sox4 and anti-glyceraldehyde-3-phosphate dehydrogenase (GAPDH) antibodies (same experiment as shown in a). The protein level is decreased to a level reflecting the decrease in RNA transcript. (c) Total RNA was analysed by quantitative RT-PCR using primers specific to Sox4 and B2M, which corroborates the RT-PCR analysis of (a). (d) Impact of Sox4 RNAi on cell viability. Cell viability was determined by MTT assay after transfection of ACC3 cells with pENTR/LacZ or pENTR/S1-1 or pENTR/S1 at the indicated time points (h). Cell viability is significantly decreased in ACC3 cells undergoing Sox4 knockdown. Bar graphs represent means7s.d. of three different experiments.
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Po0.05. The 50 probe sets most upregulated by Sox4 knockdown are shown in Table 2 . The 50 probe sets most downregulated by Sox4 knockdown are shown in Table 3 . There was substantial overlap between these two analyses, with 12 of the genes identified in the first method appearing in the 'top 50' of the ranking method. Probe sets exist in the U133a microarray for the following SOX family members: SRY, SOX1, 2, 3, 5, 9, 10, 11, 12, 13, 14, 15, 17, 18, 21, 30 . None of these probe sets showed a fold change of the means of the experimental and control groups greater than a factor of 2, and none of the probe sets achieved a significant value using a ttest analysis (all P-values>0.1). Hence, the microarray data showed no indication that any of the other Sox family members transcripts were significantly altered with the Sox4 RNAi treatment.
To show the reliability of the microarray data, four genes that were significantly differentially expressed by Sox4 knockdown, and known to be involved in apoptosis and cell cycle progression (YWHAE, CCNG2, DUSP5 and BNIP3) were chosen for validation by QRT-PCR analysis of RNA obtained from separate Sox4 knockdown experiments. Values for each gene were normalized to values obtained for GAPDH. As shown in Figure 9 , these four genes exhibited substantially increased or decreased expression, consistent with the microarray data.
Discussion
The results of our studies have verified Sox4 overexpression in ACC relative to benign glandular tissue and suggest an underlying mechanism of how Sox4 contributes to ACC tumorigenesis. Knockdown of Sox4 by gene-specific RNAi led to high level of apoptosis in ACC3 cells suggesting that Sox4 may regulate essential prosurvival pathways. One limitation of the current study is the paucity of cell culture model systems for ACC. ACC3 is the only available cell line derived from an ACC tumor that seems to maintain phenotypic characteristics of ACC. Previous studies have shown that this cell line recapitulates the myoepithelial differentiation found in primary ACC tumors (Kimura et al., 1999) and in our hands has shown gene expression profiles in microarray experiments that closely match that of primary ACC tumors (Frierson et al., 2002) . When grown as xenografts in SCID mice, ACC3 recapitulate pseudocyst structures found in primary ACC tumors (Munakata et al., 1996) . We have confirmed that ACC3 xenografts grown in nude mice form tumors with morphology consistent with grade 3 ACC (data not shown). Although this is the only ACCderived cell line currently available to us for experimental manipulation, it appears to be an appropriate model system for primary ACC tumors.
Some siRNAs have 'off-target' effects, which are often the result of partial homology to other transcripts (Jackson et al., 2003) . The experimental manipulations Sox4 knockdown induces apoptosis P Pramoonjago et al carried out in this study sought to minimize and control for such effects. Sox4 specific siRNAs were designed to avoid off-target effects by minimizing homology of siRNAs to other transcripts by BLAST search, with no significant homology detected to any other sequence in the Human Genome Database, and no significant areas of homology to the other Sox/Sry family members. Two different siRNA sequences to Sox4 (S1 and S2) showed the same proapoptotic effect, under conditions where the same concentration of control dsRNA did not show the same effect. It is unlikely that two independent siRNAs against the same transcript will target a common off-target transcript leading to the same phenotype (Berns et al., 2004) . Reverse transcriptionpolymerase chain reaction of two interferon-induced gene (Jackson et al., 2003; Sledz et al., 2003) , IRF1 and IFIT1, showed no difference in expression between experimental and control groups, indicating that induction of an interferon response was not responsible for the apoptotic effect. Finally, the specific rescue of the Sox4 RNAi-induced apoptosis by transfection with exogenous Sox4 gene construct again argues against off-target effects. The regulation of gene expression may also include translational control of protein synthesis. This phenomenon has been reported most commonly when the RNAi sequences target the 3 0 -untranslated region, when there is a partial mismatch of the 22 nucleotide RNAi sequence to the target sequence, but when the first eight nucleotides of the RNAi sequence are perfect matches (Doench and Sharp, 2004 ). Although we did not eliminate the possibility of offtarget protein translational effect of our RNAi sequences, none of the other Sox4 sequences match the first eight nucleotides of the Sox4 RNAi constructs used here (Figure 2) . The fact that when RNA and protein levels of Sox4 were measured simultaneously, there was a good match between RNA transcript loss and protein loss (Figure 4 ) also indicates that the primary mechanism of gene knockdown (at least for Sox4) is RNA transcript-mediated knockdown that requires a high degree of sequence homology between the RNAi and target sequences. Finally, the fact that two discrete 
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RNAi sequences to Sox4 show levels of apoptosis that roughly match the relative efficiency of Sox4 transcript knockdown (Figure 3 ), whereas not maintaining consistent levels of homology among the Sox gene family (Figure 2 ) is further indication that the effect seen is specific to the level of Sox4 gene product in ACC3 cells. We established three systems of introducing siRNA in ACC3 cells: transient transfection with synthetic dsRNA oligonucleotides, transient transfection with a plasmid vector producing shRNA and a stable tetracycline inducible system producing shRNA. The apoptosis phenomenon was found in every system indicating the apoptosis caused by Sox4 RNAi is real and reproducible. The ACC3 cell line does appear to be relatively prone to undergoing apoptosis owing to experimental manipulation, with a lesser degree of apoptosis seen in some of the controls containing siRNA to the bacterial gene LacZ, and a 1 bp mismatch of a Sox4 siRNA target. Although we did not detect a significant induction of the interferon response owing to the Sox4 RNAi sequences compared to a scrambled control, it is possible that ACC3 cells do mount a mild degree of nonspecific effect owing to the presence of dsRNA. A sequence-specific off-target effect is unlikely because of a similar effect is seen with both of these unrelated controls.
The Sox4 protein contains 474 amino-acid (aa) residues including an HMG-box domain as a DNAbinding domain, a serine-rich domain as a transcription activation domain and a glycine-rich domain (Farr et al., 1993; van de Wetering et al., 1993; Hur et al., 2004) . In our immunohistochemical analysis of ACC samples, Sox4 was identified in cell nuclei, consistent with its function as a transcriptional regulator that controls target gene expression. As the knockdown of Sox4-induced apoptosis in the ACC3 cell line, we speculated that some of the downstream target genes of Sox4 are involved in the inhibition of apoptosis and/ or in the promotion of cell cycle control. Microarray analysis of the knockdown experiments yielded several genes involved in these pathways that may be involved in these mechanisms (Table 4) .
A number of genes involved in the control of apoptosis were significantly differentially regulated with loss of Sox4 gene product. A pair of genes (TNFAIP3 and TNIP2) whose gene products interact to downregulate the prosurvival NF-kB pathway are predicted from our data to be downregulated by Sox4. TNFAIP (also known as A20) has both deubiquitinating and ubiquitin ligase activity that destabilize components of the NF-kB signaling pathway (Wertz et al., 2004) . TNIP2 (also known as ABIN-2) binds to TNFAIP and participates in the inhibition of NF-kB activation (Van Huffel et al., 2001) . The coordinated downregulation of these genes by Sox4 would lead to a permissive environment for the prosurvival function of NF-kB. Another proapoptotic gene product predicted to be downregulated by Sox4 is BNIP3. BNIP3 binds to BCL2 (Boyd et al., 1994) and appears to modulate mitochondrial permeability in the induction of apoptosis (Vande Velde et al., 2000) . It is induced by HIF1A during periods of cell anoxia (Sowter et al., 2001) , which is thought to occur commonly in tumorigenesis as tumor cells destroy and outgrow the local blood supply.
On the opposite side of apoptosis control, our data suggests that the anti-apoptotic gene product BIRC5 (survivin/AIP4) is upregulated by Sox4. BIRC5 is in the IAP (inhibitor of apoptosis) gene family, and the BIRC5 protein binds caspases 5 and 7, thus inhibiting apoptosis caused by a variety of mechanisms (Tamm et al., 1998) . Similarly, the anti-apoptotic gene PTMA (prothymosin) is predicted to be upregulated by Sox4. PTMA inhibits the activity of caspase 9 by inhibiting apoptosome formation (Jiang et al., 2003) . While this data needs to be verified by functional data from experimental systems, there are several strong candidate genes and pathways identified by this survey of genes affected by Sox4 knockdown to account for the apoptotic effect observed.
The induction of apoptosis caused by Sox4 knockdown in ACC3 cells may also be in part owing to dysregulation of pathways that promote the cell cycle in this tumor cell line. Several candidate genes that control Figure 7 Rescuing of the proapoptotic effect of Sry-related high mobility group box 4 (Sox4) small interfering RNA (siRNA) by exogenous Sox4. (a) An expression plasmid containing the Sox4 gene driven by a strong CMV promoter was transfected into ACC3 cells. The effect of exogenous Sox4 was measured by a luciferase reporter construct containing four Sox4-binding sites upstream of a basal promoter 48 h after transfection. A dose-dependent increase in transcription is observed, consistent with the expression of functional Sox4 protein (b). Impact of exogenous Sox4 on the proapoptotic effect of Sox4 short hairpin RNA (shRNA). ACC3 cells were engineered to contain a tet-inducible Sox4 shRNA. Cell viability was determined by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay after induction of the shRNA and transfection with various concentrations of the Sox4 expression plasmid. Bar graphs represent means7s.d. of three different experiments. Exogenous Sox4 is shown to counteract the effects of the Sox4 shRNA on cell viability in a dose-dependent manner, compared to a vector-only control.
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To our knowledge, there is no previous work that implicates Sox4 or other Sox gene family members in an antiapoptotic phenotype in tumor cells. There is evidence that other Sox/Sry family members play a role in the regulation of the cell cycle in normal growth and development. The canonical SRY gene product has been implicated in positively regulating cell proliferation in mouse gonad cells by phenotype observations in SRY deficient mice (Schmahl et al., 2000) . Conversely, other Sox proteins that are involved in differentiation pathways inhibit the cell cycle, such as Sox9 in chondrocytes, where the cell cycle inhibitor p21 is induced by Sox9 overexpression (Panda et al., 2001) . Similarly, the overexpression of Sox1 in cultured neural progenitor cells promotes neuronal lineage commitment and inhibits cell cycle (Kan et al., 2004) . These observations suggest that the Sox family of transcriptional regulators have been selected during evolution to be regulators of development in part by regulating cell cycle control.
Tumor cells in general are typically resistant to apoptosis induction and this feature allows their survival and continuous proliferation under abnormal growth stimuli (Evan and Vousden, 2001; Igney and Krammer, 2002) . Adenoid cystic carcinoma in particular is resistant to radiation and chemotherapy, consistent with a tumor resistant to proapoptotic stimuli. The successful treatment of cancer relies on the identification of targets that are specific for cancer cells and also plays a key role in promoting cell survival and cell growth. Here, we present further evidence that Sox4 is ubiquitously expressed in ACC and may be a major regulator of cell survival. To our knowledge, this is the first report of Sox4 conferring a prosurvival phenotype in a tumor cell culture model system. Given the widespread upregulation of this gene in many types of human cancer, these results may have implications for other tumors other than ACC.
Materials and methods

Tissue microarray immunohistochemistry
A tissue microarray (TMA) containing formalin-fixed paraffinembedded (FFPE) samples of ACC and non-neoplastic salivary gland was obtained from the Adenoid Cystic Carcinoma Registry (ACCR) at The University of Virginia. The FFPE tissue samples were collected from the pathology archives of contributing hospitals in which the international cohort of ACCR patients obtained their clinical care. The ACCR and the use of donated tissues operate with review and approval from the Institutional Review Board of the University of Virginia Health System. Immunohistochemistry with antigen retrieval was performed by standard methodology, as described previously . The primary antibodies were affinity purified rabbit polyclonal antibodies raised to a Sox4 peptide (aa 34-50) (Catalogue# AB5803, Chemicon International Inc., Temecula, CA, USA), diluted 1:400. For scoring, only distinct nuclear staining was considered. The percentage of positive cells in a sample was 
Cell culture
The ACC3 cell line was previously established from an ACC of the parotid gland of a 49-year-old man (He et al., 1988) and is the most widely distributed and studied cell culture model of ACC. ACC3 cells were kindly provided by Dr Takashi Saku of Niigata University School of Dentistry, Japan and were cultured in RPMI 1640 with 10% fetal calf serum, 2 mM glutamine at 371C in a humidified 5% CO 2 incubator.
RNA interference
The siRNA sequences chosen to target Sox4 were positions 1999-2019, 5 0 -AAGACGACCTGCTCGACCTG A-3 0 (S1) and 1362-1382, 5 0 -AACTCCAAACCGGCGCA-GAAA-3 0 (S2) in nonconserved regions of the Sox4 open reading frame (GenBank accession no. NM_003107). BLAST analysis shows no homology of the siRNA sequences to any other sequence in the Human Genome Database. The dsRNA nucleotides were chemically synthesized and annealed by Ambion (Ambion Inc., Austin, TX, USA). Transfection was performed on 30-40% cell confluence using lipofectamine 2000 (Life Technologies, Carlsbad, CA, Biologically active short hairpin RNAs (shRNAs) were generated from the pENTR/U6 vector (Life Technologies, Carlsbad, CA, USA), utilizing the Polymerase III U6-RNA 0 ) was introduced into pENTR/U6, resulting in pENTR/S1. The siRNA target sequence was the same target sequences of the S1 siRNA above and it was separated from the reverse complement of the same nucleotide sequence by a 4-nt linker (lower case). One plasmid clones (designated pENTR/S1) was selected for study after DNA sequencing confirmed the integrity of the shRNA sequence. Another construct (pENTR/S1-1) was isolated that contains a one basepair deletion of the Sox4 target sequence and was used as a negative control. Another control vector that targets the bacterial LacZ gene, pENTR/LacZ, was created by introducing the sequence (5 0 -GCTACACAAATCAGCGATTTc gaaAAATCGCTGATTTGTGTAGTT-3 0 ) into the pENTR/ U6 vector.
During transfection, ACC3 cells were resuspended at 5 Â 10 6 cell/ml in serum-free Opti-mem I (Life Technologies, Carlsbad, CA). Aliquots, 400 ml, were placed in 4 mm gap cuvettes, mixed with 10 mg plasmid and pulsed in a Gene Pulser II system (Bio-Rad laboratories, Hercules, CA, USA) at 0.35 kV, with 550 mF capacitance. After electroporation, cells were immediately mixed with fresh medium, transferred to a tissue culture plate, and cultured for further experiments.
To create an inducible Sox4 silencing system, ACC3 cells were first transfected with Tet repressor-expressing vector pcDNA6/TR (Life Technologies, Carlsbad, CA), followed by transfection with pSUPERIOR plasmid (OligoEngine, Seattle, WA, USA) with the S1 Sox4 RNAi sequence under tetracycline operator control, using lipofectamine 2000 (Life Technologies, Carlsbad, CA), according to the manufacturer's instruction. The cells were then subjected to double selection by blasticidin and geneticin to obtain stable transfectants containing both of the plasmids described above. Stable transfectants were treated with doxycycline to induce the expression of Sox4 siRNA.
Overexpression of Sox4 gene
Full-length human Sox4 cDNA was generated by polymerase chain reaction (PCR) amplification with pfu DNA polymerase (Stratagene, La Jolla, CA, USA) from the pCDM7-Sox4 plasmid kindly provided by Drs Marc van de Watering and Hans Clevers. The amplified fragments were inserted into the pcDNA 3.1D/V5-His-TOPO vector (Life Technologies, Carlsbad, CA). This plasmid was subsequently transfected into ACC3 cells using lipofectamine 2000. The sequence integrity and the expression of the plasmid construct were verified by DNA sequencing and Western blotting against anti-Sox4 and anti-V5 antibodies.
Reverse transcription-polymerase chain reaction and primers For semiquantitation of Sox4, IFIT1 and IRF1genes, RNA was prepared from cells 72 h after transfection using the RNeasy Mini Kit (Qiagen, Valencia, CA, USA). cDNA was synthesized in 20-ml reactions using oligo dT primer and Superscript II (Life Technologies, Carlsbad, CA). Semiquantitative PCR analysis was performed using gene specific primers, with b2-microglobulin used as an internal control in duplex reactions. 
Protein immunoblot analysis
At 72 h post-transfection, whole-cell extracts were prepared using cell lysis buffer (1% NP-40, 150 mM NaCl, 2 mM EDTA, 50 mM Tris buffer pH 8, 1 mM PMSF, 2 mg/ml aprotinin and 2 mg/ml leupeptin) and cleared by centrifugation at 12 000 g, 41C. Total protein concentration was measured using the BioRad D C protein assay kit (Bio-Rad laboratories, Hercules, CA) with bovine serum albumin as a standard. Cell lysates containing 40 mg total protein were subjected to sodium dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-PAGE) (10% acrylamide), then transferred to Immobilont-P membranes (Millipore Corporation, Bedford, MA, USA). After blocking with Tris-buffered saline (TBS) containing 0.2% nonfat-dry milk, the membranes were incubated for 3 h with antibody against Sox4 (Santa Cruz Biotechnologies, Santa Cruz, CA, USA), or glyceraldehyde-3-phosphate dehydrogenase (GAPDH) (Ambion Inc., Austin, TX) in TBS containing 0.2% nonfat-dry milk. After washing, protein on the membrane was visualized using alkaline phosphataselabeled secondary antibody (Bio-Rad laboratories, Hercules, CA) as per the manufacturer's instructions.
Cell viability assay
Cell viability was assessed by the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay (Sigma-Aldrich, Saint Louis, MO, USA) in 24-well plates at 24, 48 and 72 h post-transfection, as per the manufacturer's instructions.
Apoptosis assay
Cells were harvested and apoptotic cells were determined by TdT-mediated dUTP biotin nick end labeling (TUNEL), using the In situ Cell death Detection Kit (Roche Molecular Biochemicals, Mannheim, Germany) according to the manufacturer's instruction. Afterward, apoptosis was analysed by flow cytometry using a FACScan (BD Biosciences), and the data were processed using Cell Quest software (BD Biosciences, San Jose, CA, USA).
Cell cycle analysis
Cell cycle analysis was performed using propidium iodide staining and flow cytometry. Briefly, cells were trypsinized, washed in phosphate-buffered saline, then fixed in 75% ethanol, stained in 50 mM propidium iodide containing 5 mg/ ml DNase-free RNase, then analysed by flow cytometry using a FACScan (BD Biosciences). The data were processed using Cell Quest software (BD Biosciences). For blockade of apoptosis, after transfection, the cells were cultured in the presence of 25 mM Z-VAD-fmk (Calbiochem, La Jolla, CA, USA) for 48 h, then analysed as above. As Z-VAD was solubilized in dimethylsulphoxide (DMSO) as recommended by the manufacturer, the controls were correspondingly diluted in DMSO.
Luciferase assay A reporter plasmid bearing four copies of the AACAAG Sox4-binding site was constructed by ligating annealed oligonucleoSox4 knockdown induces apoptosis P Pramoonjago et al tides containing the binding sites upstream of the basal promoter in the pGL3 plasmid (Promega, Madison, WI, USA). ACC3 cells were transfected with an increasing amount of Sox4 overexpression plasmid together with 1 mg of pSV b-galactosidase (Promega, Madison, WI, USA) and 3 mg of the reporter plasmid using lipofectamine 2000 as mentioned above. After 48 h, the cells were harvested, the luciferase and b-galactosidase activities were measured according to the manufacturer's instruction.
Oligonucleotide microarray analysis RNA from LacZ and Sox4 knockdown ACC3 cells were prepared using the RNeasy mini kit (Qiagen, Valencia, CA, USA). Labeled cRNA was then prepared and hybridized to U133A Affymetrix oligonucleotide GeneChips (Affymetrix, Santa Clara, CA, USA) as described previously . The experiment was performed in triplicate. Data from Affymetrix U133A GeneChips were accessed utilizing the dChip software publicly available from www.dchip.org. The fluorescence data from these experiments are available at the National Center for Biotechnology Information (NCBI) Gene Expression Omnibus (GEO) website (http://www.ncbi.nlm.-nih.gov/geo/, Accession# GSE4225). Measures of gene expression and the corresponding standard errors for each of these measures were constructed utilizing the perfect-match (PM) vs mis-match (MM) difference model of Li and Wong. Differential expression was determined using two different methods. In the first method, a modified t-test was used in which the standard errors for each gene expression measurement were incorporated into the assessments of group means and variances. A significance threshold (a) was set at 0.01 for the P-values that resulted from this test for each gene. In conjunction with this filter, a second filter was applied, which required at least 75% 'present' calls for the gene expression measures of at least one group of the treatment groups analysed. The first filter determines if the signal values across the treatment groups differs significantly while the second filter ensures that these differences cannot be entirely attributed to the noise.
From this two-step filtering procedure, 25 genes were identified. As a precaution against multiple hypothesis testing error, random resampling was conducted 25 times in which the samples were placed into treatment groups randomly and the two-step filtering scheme used above was applied to each these resamplings. The median number of genes identified from the resampling technique was two genes, which thereby gives an assessment of the false discovery rate, calculated as 2/25 or 0.08. In the second method, a variation of the ranking metric system used previously in ACC gene expression profiling experiments was used (Frierson et al., 2002) . The difference and the fold change between the means of the experimental and control group were used independently to rank the data from the probe sets, and the sum of these ranks was used as a final metric of differential gene expression. A significance level of Po0.5 from the modified t-test of the data from the probe sets was used as a filter.
Quantitative real-time reverse transcription-polymerase chain reaction For validation of knockdown and microarray experiments, quantitative real-time coupled reverse transcription and polymerase chain reaction (QRT-PCR) was performed on RNA preparations from three independent samples of control and experimental cell culture conditions. RNA was extracted and cDNA synthesis was performed as described above. Quantitative real-time coupled reverse transcription and polymerase chain reaction-for Sox4 gene were performed using the icycler system (Bio-Rad laboratories, Hercules, CA). Cycling conditions were one cycle at 951C 5 min, followed by 36 cycles of 941C for 40 s, 621C for 20 s, and 721C for 30 s. The values of Sox4 gene were normalized to b2-microglobulin gene. Primers for the QRT-PCR were as follows; Sox4, forward 5 0 -AGCTTCAGCAACCAGCATTC-3 0 , reverse 5 0 -TCCCTC TCTCTCGCTCTCTC-3 0 and b2-microglobulin, forward 5 0 -TGTGCTCGCGCTACTCTCTC-3 0 , reverse 5 0 -TCTCTGCT GGATGACGTGAG-3 0 . For validation of array results, QRT-PCR was performed using TaqMan s Gene expression assays (Applied Biosystems, Foster City, CA, USA), namely Hs00356749_g1 for YWHAE, Hs00969293_m1 for BNIP3, Hs00171119_m1 for CCNG2 and Hs00244839_m1 for DUSP5, following the manufacturer's protocol. Values for each gene were normalized to expression level of GAPDH, Hs99999905_m1.
Statistical analysis
Comparison of values was performed using a nonparametric Mann-Whitney test. Po0.05 was considered statistically significant. Data are expressed as means7s.e.m. All observations were confirmed by three independent experiments, except immunohistochemistry of the TMA.
